News
News releases on January 9, 2023, page 3
Every news release public companies put out on January 9, 2023 (UTC): 496 news releases, newest first. Open any release to read it.
Viper Energy Partners LP, a Subsidiary of Diamondback Energy, Inc., Schedules Fourth Quarter 2022 Conference Call for February 22, 2023
Viper Energy, Inc. · Jan 9, 2023
Viking Therapeutics Announces Completion of Enrollment in Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic...
Viking Therapeutics, Inc. · Jan 9, 2023
urban-gro, Inc. Reports Record Backlog Heading into 2023 and Reaffirms Fourth Quarter 2022 Financial Guidance
urban-gro, Inc. · Jan 9, 2023
Univest Financial Corporation to Hold Fourth Quarter 2022 Earnings Call
Univest Financial Corporation · Jan 9, 2023
Ultra Clean Revises Fourth Quarter 2022 Guidance
Ultra Clean Holdings, Inc. · Jan 9, 2023
Udemy Announces CEO Transition
Udemy, Inc. · Jan 9, 2023
Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collaboration
Twist Bioscience Corporation · Jan 9, 2023
Trinity Capital Inc. Sets a Record with $975 Million in New Commitments for 2022
Trinity Capital Inc. · Jan 9, 2023
Treace Medical Concepts Provides 2022 Preliminary Unaudited Revenue
Treace Medical Concepts, Inc. · Jan 9, 2023
Travere Therapeutics Provides Corporate Update and 2023 Outlook
Travere Therapeutics, Inc. · Jan 9, 2023
Tilray Brands Reports Second Quarter Fiscal Year 2023 Financial Results
Tilray Brands, Inc. · Jan 9, 2023
Tigo Energy Announces $50 Million Capital Raise to Support Growth Initiatives
Tigo Energy, Inc. · Jan 9, 2023
Theravance Biopharma, Inc. Highlights 2022 Accomplishments and 2023 Key Targets
Theravance Biopharma, Inc. · Jan 9, 2023
Texas Roadhouse, Inc. Appoints Gina Tobin President
Texas Roadhouse, Inc. · Jan 9, 2023
TeraWulf Announces December 2022 Production and Operations Updates
TeraWulf Inc. · Jan 9, 2023
Tenaya Therapeutics Announces TN-201 IND Clearance and Anticipated 2023 Milestones
Tenaya Therapeutics, Inc. · Jan 9, 2023
TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgi...
TELA Bio, Inc. · Jan 9, 2023
Take-Two Interactive Software, Inc. to Report Third Quarter Fiscal Year 2023 Results on Monday, February 6, 2023
Take-Two Interactive Software, Inc. · Jan 9, 2023
Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans i...
Sutro Biopharma, Inc. · Jan 9, 2023
Surgery Partners, Inc. Reaffirms 2022 Full Year Guidance
Surgery Partners, Inc. · Jan 9, 2023
Surge Copper Identifies New Copper-Gold Porphyry Potential 300 metres Northeast of the East Seel Deposit Intersecting 100 metres grading ...
Surge Copper Corp. · Jan 9, 2023
Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2023
Stoke Therapeutics, Inc. · Jan 9, 2023
Steel Dynamics Announces Fourth Quarter and Full-Year 2022 Earnings Conference Call and Webcast
Steel Dynamics, Inc. · Jan 9, 2023
Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update
Standard BioTools Inc. · Jan 9, 2023
STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022
STAAR Surgical Company · Jan 9, 2023
Spruce Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023
Spruce Biosciences, Inc. · Jan 9, 2023
Sotera Health Chairman and CEO Presents at 41st Annual J.P. Morgan Healthcare Conference
Sotera Health Company · Jan 9, 2023
Sotera Health Announces Settlement of Ethylene Oxide Litigation in Illinois
Sotera Health Company · Jan 9, 2023
Solid Biosciences Reports Inducement Grant to Chief Financial Officer and Treasurer
Solid Biosciences Inc. · Jan 9, 2023
Solid Biosciences Appoints Kevin Tan, CFA, as Chief Financial Officer
Solid Biosciences Inc. · Jan 9, 2023
SiriusXM to Report Fourth Quarter and Full Year 2022 Financial and Operating Results
SiriusXM Holdings Inc. · Jan 9, 2023
Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results
Sight Sciences, Inc. · Jan 9, 2023
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2022
SI-BONE, Inc. · Jan 9, 2023
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2023
Shattuck Labs, Inc. · Jan 9, 2023
Sensus Healthcare Announces Senior Management Appointments and Promotions
Sensus Healthcare, Inc. · Jan 9, 2023
Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance
GeneDx Holdings Corp. · Jan 9, 2023
SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in...
SeaStar Medical Holding Corporation · Jan 9, 2023
Scotch Creek Ventures Successfully Completes Second Drill Hole at its Macallan East Lithium Project
Scotch Creek Ventures, Inc. · Jan 9, 2023
SciSparc Signs Agreement to Conduct its Clinical Trial in Autism Spectrum Disorder with Soroka Medical Center
SciSparc Ltd. · Jan 9, 2023
Schrödinger Provides Update on Progress Across the Business and Outlines 2023 Company Strategic Priorities
Schrodinger, Inc. · Jan 9, 2023
Scholar Rock Provides Corporate Update and Highlights Priorities for 2023
Scholar Rock Holding Corporation · Jan 9, 2023
Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2022 Net Product Revenues
Sarepta Therapeutics, Inc. · Jan 9, 2023
Saia to Announce Fourth Quarter 2022 Results on February 3, 2023
Saia, Inc. · Jan 9, 2023
Sabra Health Care REIT, Inc. to Attend ASHA’s 2023 Annual Meeting
Sabra Health Care REIT, Inc. · Jan 9, 2023
Royalty Pharma Highlights Accomplishments and Provides Business Update at 41st Annual J.P. Morgan Healthcare Conference
Royalty Pharma plc · Jan 9, 2023
Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to $1.1 Billion to Further Advance Ionis’ Genetic Medicines and Commercial R...
Ionis Pharmaceuticals, Inc. · Jan 9, 2023
Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to $1.1 Billion to Further Advance Ionis’ Genetic Medicines and Commercial R...
Royalty Pharma plc · Jan 9, 2023
Rockland Trust Company and Independent Bank Corp. Appoint Jeffrey J. Tengel as Chief Executive Officer
Independent Bank Corp. · Jan 9, 2023
Rocket Pharmaceuticals Expands Cardiac Gene Therapy Portfolio with Addition of RP-A601 for PKP2-ACM and Announces Positive Updated Phase ...
Rocket Pharmaceuticals, Inc. · Jan 9, 2023
Rock Edge Resources Appoints David Leslie Hamilton-Smith as President
Inspiration Mining Corp. · Jan 9, 2023
Rivian Sets Date for Release of Fourth Quarter and Full Year 2022 Results
Rivian Automotive, Inc. · Jan 9, 2023
Rigel Pharmaceuticals Provides Business Update
Rigel Pharmaceuticals, Inc. · Jan 9, 2023
Revival Gold Intersects 1.12 g/t Gold Over 18 Meters and 0.81 g/t Gold Over 30.1 Meters in Near-Surface Oxides at Haidee
Revival Gold Inc · Jan 9, 2023
Relmada Therapeutics Appoints CNS Therapeutic Expert Cedric O'Gorman MD as Chief Medical Officer
Relmada Therapeutics, Inc. · Jan 9, 2023
REGENXBIO announces senior leadership promotions
Regenxbio Inc. · Jan 9, 2023
Red Rock Resorts Announces Fourth Quarter and Full Year 2022 Conference Call and Earnings Release Date
Red Rock Resorts, Inc. · Jan 9, 2023
Red Robin Gourmet Burgers, Inc. Releases “North Star” Five-Point Plan to Drive Long-Term Shareholder Value
Red Robin Gourmet Burgers, Inc. · Jan 9, 2023
Quantum-Si Begins Commercial Shipments of the PlatinumTM Protein Sequencing System and Provides Business Updates at the 41st Annual J.P. ...
Quantum-Si Incorporated · Jan 9, 2023
Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test
Quanterix Corporation · Jan 9, 2023
Quanterix Announces Appointment of Brian Blaser to Board of Directors
Quanterix Corporation · Jan 9, 2023
Pure Cycle Announces Financial Results for the Three Months Ended November 30, 2022
Pure Cycle Corporation · Jan 9, 2023
Puma Biotechnology Releases Updated Corporate Presentation
Puma Biotechnology Inc · Jan 9, 2023
PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 41st Annual J.P. Morgan Healthcare Conference
PTC Therapeutics, Inc. · Jan 9, 2023
Prosper Gold Reports Drill Results and Prepares IP Survey at Golden Sidewalk Project, Red Lake, ON
Prosper Gold Corp. · Jan 9, 2023
Progyny to Discuss its Strong 2022 Financial Performance at Upcoming Investor Conference
Progyny, Inc. · Jan 9, 2023
PROCEPT BioRobotics Announces Preliminary Fourth Quarter and Fiscal Year 2022 Revenue
PROCEPT BioRobotics Corporation · Jan 9, 2023
Prismo Metals and Vizsla Silver Complete Strategic Investment
Prismo Metals Inc. · Jan 9, 2023
Principal® to Announce Fourth Quarter and Full Year 2022 Financial Results
Principal Financial Group Inc · Jan 9, 2023
PriceSmart announces fiscal 2023 first quarter operating results
PriceSmart, Inc. · Jan 9, 2023
Precision BioSciences Recaps 2022 Accomplishments and Outlines 2023 Corporate Priorities and Planned Portfolio Milestones
Precision BioSciences, Inc. · Jan 9, 2023
PLBY Group Amends Rights Offering
Playboy, Inc. · Jan 9, 2023
Plains All American Pipeline and Plains GP Holdings Announce Timing of Fourth-Quarter and Full-Year 2022 Earnings
Plains All American Pipeline, L.P. · Jan 9, 2023
Plains All American Pipeline and Plains GP Holdings Announce Timing of Fourth-Quarter and Full-Year 2022 Earnings
Plains GP Holdings, L.P. · Jan 9, 2023
Plains All American Pipeline and Plains GP Holdings Announce Distributions
Plains All American Pipeline, L.P. · Jan 9, 2023
Plains All American Pipeline and Plains GP Holdings Announce Distributions
Plains GP Holdings, L.P. · Jan 9, 2023
Pioneer Power Continues Accelerating e-Boost Commercialization,Generates Additional Orders
Pioneer Power Solutions, Inc. · Jan 9, 2023
Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2022 Quarterly Financial Results
Phibro Animal Health Corporation · Jan 9, 2023
Pharvaris Provides Regulatory, Clinical, and Corporate Updates
Pharvaris N.V. · Jan 9, 2023
Patriot Battery Metals Appoints Vice President ESG and Senior Advisor Environment and Permitting to its Team
PMET Resources Inc. · Jan 9, 2023
Palantir Introduces Quality Management System for Life Sciences
Palantir Technologies Inc. · Jan 9, 2023
PacBio Announces Record Orders, Including Orders for 76 Revio Systems Received in the Fourth Quarter of 2022
Pacific Biosciences of California, Inc. · Jan 9, 2023
PacBio and the University of Tokyo Announce Bioinformatics Applications Collaboration
Pacific Biosciences of California, Inc. · Jan 9, 2023
Outset Medical Reports Expected Fourth Quarter and Full Year 2022 Revenue, Provides 2023 Revenue and non-GAAP Gross Margin Guidance
Outset Medical, Inc. · Jan 9, 2023
OrthoPediatrics Corp. Announces Preliminary Unaudited Net Revenue for the Fourth Quarter & Full Year 2022, Provides Financial Outlook for...
OrthoPediatrics Corp. · Jan 9, 2023
Orthofix Medical Inc. Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results
Orthofix Medical Inc. · Jan 9, 2023
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones
Oric Pharmaceuticals, Inc. · Jan 9, 2023
OneSpaWorld Announces Preliminary Fiscal 2022 Results and Introduces Fiscal 2023 Guidance
OneSpaWorld Holdings Limited · Jan 9, 2023
Ocuphire Pharma Announces First Patient Enrolled in VEGA-2 Pivotal Phase 3 Trial of Nyxol® in Presbyopia
Viatris Inc. · Jan 9, 2023
Ocugen Announces Positive Top-Line Data for COVID-19 Vaccine Candidate COVAXIN™ (BBV152) in Phase 2/3 Immuno-bridging and Broadening Stud...
Ocugen, Inc. · Jan 9, 2023
Oak Valley Community Bank Receives Multiple SBA and Valley Small Business Lending Accolades
Oak Valley Bancorp · Jan 9, 2023
Oaktree Specialty Lending Corporation Schedules First Fiscal Quarter Earnings Conference Call for February 7, 2023
Oaktree Specialty Lending Corporation · Jan 9, 2023
Nuwellis Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results
Nuwellis, Inc. · Jan 9, 2023
Nurix Therapeutics Advances Promising Targeted Protein Modulation Pipeline and Outlines 2023 Strategic Priorities
Nurix Therapeutics, Inc. · Jan 9, 2023
Novocure Announces Preliminary Full Year and Fourth Quarter 2022 Net Revenues and Provides Company Update
NovoCure Limited · Jan 9, 2023
Novavax Names John C. Jacobs as New President & Chief Executive Officer
Novavax, Inc. · Jan 9, 2023
Nova to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023
Nova Ltd. · Jan 9, 2023
Northwest Copper Reports 41.20 Metres of 3.20% Copper Equivalent at Stardust From Drilling in the 421 Zone
NorthWest Copper Corp. · Jan 9, 2023
Nkarta Promotes David R. Shook, M.D., to Chief Medical Officer
Nkarta, Inc. · Jan 9, 2023
NGEx Minerals Begins Potro Cliffs Drill Program in Argentina
NGEx Minerals Ltd. · Jan 9, 2023
New Study Evaluates the Performance of Masimo SpHb® Noninvasive Spot-Check Hemoglobin in the Emergency Department
Masimo Corporation · Jan 9, 2023